Langenfeld, Germany, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Booking Health, a global facilitator of international medical care, announced today a timely initiative aimed at improving access to advanced ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

Alecensa reduced death risk by 22% compared to Xalkori in advanced ALK-positive NSCLC, with a median OS of 81.1 months versus 54.2 months. The study was not powered for OS, resulting in ...

The COCOON trial demonstrated that a new skin care regimen reduces dermatologic side effects in EGFR-mutated NSCLC patients, improving quality of life and emotional well-being. Osimertinib, as shown ...

Please provide your email address to receive an email when new articles are posted on . DREAM program at Northwestern offers lung transplants to patients with advanced, localized lung cancer. Patients ...

High levels of IB6 are often found in NSCLC, making it a good target for treatment. A preclinical study found that in lung cancer, IB6 was correlated with interleukin-8 levels and promoted cancer cell ...

Yes, lung cancer can be curable — if it’s found early and responds well to treatment. Thanks to recent therapy advances, the lung cancer mortality rate has declined and survival rates have improved.

The pharmaceutical company said its ceralasertib combination didn’t meet the primary goal of a late-stage clinical trial for ...

“Lung cancer, though common and serious, still has many misconceptions,” says Ian Bostock, MD, a thoracic surgeon at Miami Cancer Institute in Florida. “Clearing these myths helps patients and ...

In his 20-year research career in Colorado, University of Colorado Cancer Center member D. Ross Camidge, MD, PhD, has published nearly 400 academic papers. But perhaps none have been so personal to ...